Paris polyphylla Smith extract induces apoptosis and activates cancer suppressor gene connexin26 expression

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Targeting tumor cell growth without harming normal cells is crucial in cancer therapy.
• Medicinal plants like Paris polyphylla Smith offer potential anticancer agents with reduced toxicity.
• The anti-tumor mechanisms of Paris polyphylla Smith, particularly its effects on connexin26, require further elucidation.

Purpose of the Study:

• To investigate the effects of Paris polyphylla Smith extract (PPSE) on connexin26 expression in human esophageal cancer cells.
• To determine the impact of PPSE on the growth and proliferation of esophageal cancer ECA109 cells.
• To explore the potential of PPSE as a therapeutic agent for esophageal cancer.

Main Methods:

• Quantitative real-time PCR (RT-PCR) and Western blot were used to assess connexin26 mRNA and protein levels.
• Immunofluorescence was employed to visualize connexin26 expression.
• The MTT assay was utilized to evaluate cell viability and proliferation.

Main Results:

• PPSE significantly inhibited the growth and proliferation of human esophageal cancer ECA109 cells.
• PPSE treatment led to increased expression of connexin26 at both mRNA and protein levels.
• PPSE modulated apoptosis-related proteins, decreasing Bcl-2 and increasing Bad expression.

Conclusions:

• This study demonstrates that PPSE enhances connexin26 expression at the mRNA and protein levels.
• PPSE exerts anti-tumor effects on esophageal cancer cells by inhibiting proliferation and inducing apoptosis.
• PPSE represents a promising natural compound for esophageal cancer therapy, warranting further investigation.